目的 介绍国外药师门诊的形成背景、发展历程以及常见的药师门诊开展项目,以了解外国药师门诊开展情况,为我国医院药学的发展和药师门诊的建立完善提供参考和借鉴。方法 以“药师门诊”、“药物治疗管理”为检索词在PubMed、知网、万方等数据库中查阅近20年的相关研究文献,阅览各大医药论坛和网站中对于药师门诊开展的相关报道,总结相关临床研究案例,分析和评价药师门诊开展的效果。结果与结论 药师门诊的开展可以提高患者用药依从性,在保证药物疗效的前提下降低因药物相互作用及不良反应等造成的药源性疾病的发生率和再次入院率,同时降低医疗费用,促进医疗资源的合理分配,对我国医院药学的发展和国民健康的改善具有重要意义。
Abstract
OBJECTIVE To introduce the formation background, development course and common service items of foreign pharmacist-managed clinic, deepen our understanding of its development satus,and provide us a reference of hospital pharmacy development and pharmacist-managed clinic build. METHODS We search key words“pharmacist-managed clinic”and “medication therapy management” in database PubMed,CNKI and WANFANG DATA,then find out and read relevant research literatures published in recent 20 years. Browse the medical forum and website for related reports of pharmacist-managed clinic. Sum up the relevant clinical research cases, analyze and evaluate the effect of pharmacist-managed clinic. RESULTS AND CONCLUSION We can conclude that the development of pharmacist-managed clinic can improve the compliance of patients with medication, reduce the incidence of drug-related diseases and hospitalization rates due to drug interactions and adverse reactions under the premise of ensuring the efficacy of drugs, while reducing medical expenses and promoting the rational allocation of medical resources,which is of great significance to the development of hospital medicine and the improvement of national health.
关键词
药师门诊 /
药物治疗管理 /
医院药学
{{custom_keyword}} /
Key words
pharmacist-managed clinic /
medication therapy management /
hospital pharmacy
{{custom_keyword}} /
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] SHAH M, MARKEL VAYSMAN A, WILKEN L. Medication therapy management clinic: perception of healthcare professionals in a University medical center setting[J]. Pharm Pract, 2013, 11(3):173-177.
[2] SHAH M, TILTON J, KIM S. Factors influencing enrollment in the medication therapy management clinic at an academic ambulatory care clinic[J]. J Pharm Pract, 2016, 29(2):106-109.
[3] JOHNSON J A, BOOTMAN J L. Drug-related morbidity and mortality and the economic impact of pharmaceutical care[J]. Am J Health-Syst Pharm, 1997(54):554-558.
[4] GARTON L, CROSBY J F. A retrospective assessment comparing pharmacist-managed anticoagulation clinic with physician management using international normalized ratio stability[J]. J Thromb Thrombolys, 2011, 32(4):426-430.
[5] ELEWA H, JALALI F, KHUDAIR N, et al. Evaluation of pharmacist-based compared to doctor-based anticoagulation management in Qatar[J]. J Eval Clin Pract, 2016(22):433-438.
[6] SAOKAEW S, SAPOO U, NATHISUWAN S, et al. Anticoagulation control of pharmacist-managed collaborative care versus usual care in Thailand[J]. Int J Clin Pharm-Net, 2012, 34(1):105-112.
[7] VIVIAN E M. Improving blood pressure control in a pharmacist-managed hypertension clinic[J]. Pharmacotherapy, 2002, 12(22):1533-1540.
[8] MARK P, RANDY K. Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic[J]. Pharmacotherapy, 2001, 11(21):1337-1344.
[9] CHIENG R, COUTSOUVELIS J, POOLE S, et al. Improving the transition of highly complex patients into the community: impact of a pharmacist in an allogeneic stem cell transplant (SCT) outpatient clinic[J]. Support Care Cancer, 2013, 21(12):3491-3495.
[10] CORDING M A, ENGELBRECHT-ZADVORNY E B, PETTIT B J, et al. Development of a pharmacist-managed lipid clinic[J]. Ann Pharmacother, 2002,36(5):892-904.
[11] YAMADA K, NABESHIMA T. Pharmacist-managed clinics for patient education and counseling in Japan: current status and future perspectives[J]. J Pharm Health Care Sci, 2015, 1(1):2.
[12] BEDOUCH P, ROUSTIT M, QUETANT S, et al. Development of a pharmacist collaborative care program for pulmonary arterial hypertension[J]. Int J Clin Pharm-Net, 2011, 33(6):898-901.
[13] WILLIAMS T, PURVIS T L. Development of an outpatient pharmacist-managed clozapine clinic[J]. Am J Health-Syst Pharm, 2012,69(14):1192-1194.
[14] GARWOOD C L, DUMO P, BARINGHAUS S N, et al. Quality of anticoagulation care in patients discharged from a pharmacist-managed anticoagulation clinic after stabilization[J]. Pharm Cother, 2008, 1(28):20-26.
[15] TAVITIAN S M, SPALEK V H, BAILEY R P. A pharmacist-managed clinic for treatment of latent tuberculosis infection in health care workers[J]. Am J Health-Syst Pharm, 2003,60(18):1856-1861.
[16] WILLIAMS T, PURVIS T L. Development of an outpatient pharmacist-managed clozapine clinic[J]. Am J Health-Syst Pharm, 2012,69(14):1194-1195.
[17] SMITH J P, DONG M H, KAUNITZ J D. Evaluation of a pharmacist-managed hepatitis C care clinic[J]. Am J Health-Syst Ph, 2007, 64(6):632-636.
[18] MORELLO C M. Development and clinical outcomes of pharmacist-managed diabetes care clinics[J]. Am J Health-Syst Ph, 2006, 63(14):1325-1331.
[19] GERRALD K R, DIXON D L, BARNETTE D J, et al. Evaluation of a pharmacist-managed lipid clinic that uses point-of-care lipid testing[J]. J Clin Lipidol, 2010, 4(2):120-125.
[20] WONG L, CHUA S, HUSIN A, et al. A pharmacy management service for adults with asthma: a cluster randomised controlled trial[J]. Fam Pract, 2017: 1-10.
[21] MARTINEZ A S, SAEF J, PASZCZUK A, et al. Implementation of a pharmacist-managed heart failure medication titration clinic[J]. Am J Health-Syst Ph, 2013, 70(12):1070-1076.
[22] ROSE O, SCHAFFERT C, CZARNECKI K, et al. Effect evaluation of an interprofessional medication therapy management approach for multimorbid patients in primary care: a cluster-randomized controlled trial in community care (WestGem study protocol)[J]. Bmc Fam Pract, 2015, 16(1):84.
[23] ZILLICH A J, SNYDER M E, FRAIL C K, et al. A randomized, controlled pragmatic trial of telephonic medication therapy management to reduce hospitalization in home health patients[J]. Health Serv Res, 2014, 49(5):1537-1554.
[24] MOCZYGEMBA L R, BARNER J, BRANNIER J C, et al. Outcomes of a medicare part D telephone medication therapy management program[J]. J Am Pharm Assoc, 2012,52(6):144-152.
[25] LAM A.Practice innovations: delivering medication therapy management services via videoconference interviews[J]. The Consultant Pharmacist, 2011, 10(26):764-774.
[26] PLANAS L G, CROSBY K M, MITCHELL K D, et al. Evaluation of a hypertension medication therapy management program in patients with diabetes.[J]. J Am Pharm Assoc, 2009,49(2):164-170.
[27] WELCH E K, DELATE T, CHESTER E A, et al. Assessment of the impact of medication therapy management delivered to home-based medicare beneficiaries[J]. Ann Pharmacother, 2009, 43(4):603-610.
[28] CHEN C, KUO L, CHENG K, et al. The effect of medication therapy management service combined with a national pharma cloud system for polypharmacy patients[J]. Comput Meth Prog Bio, 2016, 134: 109-119.
[29] HENRICHSMANN M, HEMPEL G.Impact of medication therapy management in patients with Parkinson′s disease[J]. Int J Clin Pharm-Net, 2016, 38(1):54-60.
[30] WANG J, HONG S H. Contingent valuation and pharmacists′ acceptable levels of compensation for medication therapy management services[J]. Res Soc Admin Pharm, 2015, 11(3):121-132.
[31] DE OLIVEIRA D R, BRUMMEL A R, MILLER D B. Medication therapy management: 10 years of experience in a large integrated health care system[J]. J Manage Care Pharm, 2010, 3(16):185-195.
[32] CHEN Z, ERNST M E, ARDERY G, et al. Physician-pharmacist co-management and 24-hour blood pressure control[J]. J Clin Hyper, 2013, 15(5):337-343.
[33] HUANG C, NGUYEN P A, CLINCIU D L, et al. A personalized medication management platform (PMMP) to improve medication adherence: a randomized control trial[J]. Comput Meth Prog Bio, 2017, 140: 275-281.
[34] HONG L L, HUI M W, HUI S H, et al. Perspectives on development direction of hospital pharmacy and working mode of pharmacist under the new condition of medical reform[J]. Chin Pharm J(中国药学杂志), 2015, 50(20):1836-1840.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
PDF(1221 KB)
